BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9005957)

  • 21. Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates.
    Fraser CC; Altreuter DH; Ilyinskii P; Pittet L; LaMothe RA; Keegan M; Johnston L; Kishimoto TK
    Vaccine; 2014 May; 32(24):2896-903. PubMed ID: 24583006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2.
    Fayette J; Dubois B; Vandenabeele S; Bridon JM; Vanbervliet B; Durand I; Banchereau J; Caux C; Brière F
    J Exp Med; 1997 Jun; 185(11):1909-18. PubMed ID: 9166420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.
    Chin LT; Hinkula J; Levi M; Ohlin M; Wahren B; Borrebaeck CA
    Immunology; 1994 Mar; 81(3):428-34. PubMed ID: 7515847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody potential of human peripheral blood lymphocytes differentially expressing surface membrane IgM.
    Thiele CJ; Stevens RH
    J Immunol; 1980 Apr; 124(4):1898-904. PubMed ID: 6767777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4.
    Avery DT; Bryant VL; Ma CS; de Waal Malefyt R; Tangye SG
    J Immunol; 2008 Aug; 181(3):1767-79. PubMed ID: 18641314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.
    Fais F; Sellars B; Ghiotto F; Yan XJ; Dono M; Allen SL; Budman D; Dittmar K; Kolitz J; Lichtman SM; Schulman P; Schuster M; Vinciguerra VP; Rai K; Stevenson FK; Gregersen PK; Ferrarini M; Chiorazzi N
    J Clin Invest; 1996 Oct; 98(7):1659-66. PubMed ID: 8833916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory.
    Martin SW; Goodnow CC
    Nat Immunol; 2002 Feb; 3(2):182-8. PubMed ID: 11812996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-dependent regulation of IgE antibody production by human antigen-specific B cells.
    Oshiba A; Gelfand EW
    J Immunol; 1996 Dec; 157(11):4870-5. PubMed ID: 8943390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. Discrepancy between T cell-dependent and T cell-independent activation.
    Teeuwsen VJ; Logtenberg T; Siebelink KH; Lange JM; Goudsmit J; Uytdehaag FG; Osterhaus AD
    J Immunol; 1987 Nov; 139(9):2929-35. PubMed ID: 3499462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of T- and B-cell epitopes in synthetic peptides derived from a Streptococcus mutans protein and characterization of their antigenicity and immunogenicity.
    Lehner T; Walker P; Smerdon R; Childerstone A; Bergmeier LA; Haron J
    Arch Oral Biol; 1990; 35 Suppl():39S-45S. PubMed ID: 1708230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ig isotype switching in B lymphocytes. The effect of T cell-derived interleukins, cytokines, cholera toxin, and antigen on isotype switch frequency of a cloned B cell lymphoma.
    Whitmore AC; Prowse DM; Haughton G; Arnold LW
    Int Immunol; 1991 Jan; 3(1):95-103. PubMed ID: 2049338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras.
    Murphy WJ; Funakoshi S; Fanslow WC; Rager HC; Taub DD; Longo DL
    Clin Immunol; 1999 Jan; 90(1):22-7. PubMed ID: 9884349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.
    Stevens RH; Saxon A
    J Clin Invest; 1978 Dec; 62(6):1154-60. PubMed ID: 311781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD40 stimulation of human peripheral B lymphocytes: distinct response from naive and memory cells.
    Fecteau JF; Néron S
    J Immunol; 2003 Nov; 171(9):4621-9. PubMed ID: 14568936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo.
    Böcher WO; Marcus H; Shakarchy R; Dekel B; Shouval D; Galun E; Reisner Y
    Immunology; 1999 Apr; 96(4):634-41. PubMed ID: 10233752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
    Lumsden JM; Williams JA; Hodes RJ
    J Immunol; 2003 Jan; 170(2):781-7. PubMed ID: 12517941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
    Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
    J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presentation of high antigen-dose by splenic B220(lo) B cells fosters a feedback loop between T helper type 2 memory and antibody isotype switching.
    Ellis JS; Guloglu FB; Zaghouani H
    Immunology; 2016 Apr; 147(4):464-75. PubMed ID: 26749165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.
    Vajdy M; Lycke N
    Immunology; 1993 Oct; 80(2):197-203. PubMed ID: 7505255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.